Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.

Expert review of gastroenterology & hepatology - 1 Feb 2010

De Vos Martine

Abstract excerpt

Joint inflammation is present in approximately 30% of patients with inflammatory bowel disease. Peripheral arthritis can frequently be controlled by an optimal treatment of the gut inflammation in association with short-term use of NSAIDs. Recurrent inflammation requires the use of sulfasalazine. More therapy-resistant forms and axial arthropathy can be treated with anti-TNF drugs, predominantly infliximab and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adalimumab
Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Monoclonal, Humanized

Share to Arthritis

Share to Inflammatory Bowel Diseases

Share to Infliximab

Source

Identifiers

PMID: 20136591
DOI: 10.1586/egh.09.75

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.PMID 20136591Read ↗

Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis.Semantic proximity Read ↗

Inflammatory bowel disease: the classic gastrointestinal autoimmune disease.Semantic proximity Read ↗

Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms.Semantic proximity Read ↗

Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.Semantic proximity Read ↗

Inflammatory bowel disease: beyond the boundaries of the bowel.Semantic proximity Read ↗

Introduction: Inflammatory bowel disease: a complex systemic disease engaging multiple players outside the immune system.Semantic proximity Read ↗

Update in the management of extraintestinal manifestations of inflammatory bowel disease.Semantic proximity Read ↗

Recent advances in ankylosing spondylitis: understanding the disease and managementSemantic proximity Read ↗

Immunomodulators in inflammatory bowel disease: an emerging role for biologic agents.Semantic proximity Read ↗

[Inflammatory bowel disease: pathogenesis and therapy].Semantic proximity Read ↗

Diagnosis and management of inflammatory bowel disease in children.Semantic proximity Read ↗

Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.